CVS Health CVS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 179.4%-0.1pp | 179.4%+0.3pp | 179.1%+1.3pp | 177.8%+2.7pp | 175.1%+4.0pp | |
| Operating margin | 6.2%-1.1pp | 7.3%-1.1pp | 8.4%-1.3pp | 9.7%-1.1pp | 10.8%-0.9pp | |
| Net margin | 2.4%-0.7pp | 3.1%-0.8pp | 3.9%-1.2pp | 5.2%-0.8pp | 6%-0.6pp | |
| EBITDA margin | 10.8%-1.2pp | 12%-1.2pp | 13.2%-1.4pp | 14.6%-1.1pp | 15.8%-1.0pp | |
| Returns | ||||||
| Return on equity | 12.7%-3.2pp | 15.9%-3.7pp | 19.7%-6.1pp | 25.7%-3.8pp | 29.5%-3.1pp | |
| Return on assets | 3.8%-0.9pp | 4.7%-1.1pp | 5.9%-1.8pp | 7.7%-1.1pp | 8.8%-0.9pp | |
| Return on invested capital | 18.1%-1.2pp | 19.2%-0.3pp | 19.5%-3.2pp | 22.7%-1.0pp | 23.7%-0.2pp | |
| Efficiency | ||||||
| Asset turnover | 6.3×+0.1× | 6.2×+0.1× | 6×+0.1× | 6×+0.1× | 5.9×0.0× | |
| Inventory turnover | 49.3×+0.4× | 48.9×+0.4× | 48.4×+0.2× | 48.3×+0.1× | 48.1×+0.1× | |
| Liquidity | ||||||
| Current ratio | 3.3×0.0× | 3.3×0.0× | 3.3×0.0× | 3.2×-0.1× | 3.3×0.0× | |
| Quick ratio | 2.5×0.0× | 2.5×0.0× | 2.5×0.0× | 2.4×0.0× | 2.5×0.0× | |
| Cash ratio | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.5×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 1.8×0.0× | 1.9×-0.9× | 2.8×0.0× | 2.8×-0.9× | 3.6×0.0× | |
| Debt-to-assets | 0.5×0.0× | 0.5×-0.3× | 0.8×0.0× | 0.8×-0.3× | 1.1×0.0× | |
| Net debt / EBITDA | 9.8×0.0× | 9.8×-5.0× | 14.8×+2.4× | 12.5×-3.7× | 16.2×-0.1× | |
| Interest coverage | 7.9×-1.3× | 9.2×-1.4× | 10.6×-1.7× | 12.3×-1.4× | 13.7×-1.3× | |
| Per Share | ||||||
| Book value per share | $238.13-0.1% | $238.44-0.3% | $239.13-0.9% | $241.19+0.6% | $239.78+1.0% | |
| Valuation | ||||||
| Market capitalization | $373.22B+1.6% | $367.27B+13.7% | $323.02B+5.4% | $306.5B+3.8% | $295.15B-4.8% | |
| Enterprise value | $468.93B+0.9% | $464.93B-5.2% | $490.2B+2.9% | $476.42B-10.1% | $530.2B-3.2% | |
| Price / earnings | 310.9×+15.0× | 295.9×+44.7× | 251.2×+188× | 63.1×+8.6× | 54.5×+2.5× | |
| Price / sales | 0.9×0.0× | 0.9×+0.1× | 0.8×0.0× | 0.8×0.0× | 0.8×-0.1× | |
| Price / book | 4.9×+0.1× | 4.9×+0.6× | 4.3×+0.3× | 4×+0.1× | 3.9×-0.2× | |
| EV / EBITDA | 45.7×+2.7× | 43×+1.5× | 41.5×+6.8× | 34.7×-1.8× | 36.5×0.0× | |
| EV / sales | 1.2×0.0× | 1.2×-0.1× | 1.3×0.0× | 1.3×-0.2× | 1.4×-0.1× | |
| Earnings yield | 10.8%-3.0pp | 13.7%-6.4pp | 20.1%-5.9pp | 26%-4.4pp | 30.4%-1.1pp | |
| Dividend yield | 14.6%-0.2pp | 14.8%-2.6pp | 17.4%-0.6pp | 18.1%-0.4pp | 18.5%+0.8pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CVS Health's profit margins?
- CVS Health (CVS) runs a 44.7% gross margin and a 1.5% operating margin, with a 0.7% net margin.
- Where do CVS Health's ratios come from?
- Every ratio is computed from CVS Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
